Trial Details
WITHDRAWNBasic Information
| Clinical ID | c18 |
|---|---|
| Identifier | NCT03414788 |
| Trial Title | Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease |
| Interventions | BIOLOGICAL: PF 06687234|BIOLOGICAL: [124I]IB PF 06687234 |
Participant Information
| Sponsor | Pfizer |
|---|---|
| City | New Haven |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2020-12-07 |
|---|---|
| Primary Completion Date | 2022-02-01 |
| Completion Date | 2022-02-01 |